Related references
Note: Only part of the references are listed.Promising Treatment for Multiple Sclerosis: Mitochondrial Transplantation
Pasquale Picone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The mitochondrial stress responses: the Dr. Jekyll and Mr. Hyde of neuronal disorders
Simone Patergnani et al.
NEURAL REGENERATION RESEARCH (2022)
Hypoxia in multiple sclerosis; is it he chicken or the egg?
Sebok K. Halder et al.
BRAIN (2021)
Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics
Anna Signorile et al.
ANTIOXIDANTS (2021)
Mitochondrial dysfunction and serum lactate as a biomarker for the progression and disability in MS and its correlation with the radiological findings
Ahmed Esmael et al.
NEUROLOGICAL RESEARCH (2021)
Enhancing mitochondrial activity in neurons protects against neurodegeneration in a mouse model of multiple sclerosis
Sina C. Rosenkranz et al.
ELIFE (2021)
Unraveling the Link Between Mitochondrial Dynamics and Neuroinflammation
Lilian Gomes de Oliveira et al.
FRONTIERS IN IMMUNOLOGY (2021)
Therapeutic Potential and Immunomodulatory Role of Coenzyme Q10 and Its Analogues in Systemic Autoimmune Diseases
Chary Lopez-Pedrera et al.
ANTIOXIDANTS (2021)
Potential of PINK1 and PARKIN Proteins as Biomarkers for Active Multiple Sclerosis: A Japanese Cohort Study
Davide Cossu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases
Miranda D. Chavez et al.
FRONTIERS IN IMMUNOLOGY (2021)
Hypoxia in multiple sclerosis; is it the chicken or the egg?
Sebok K. Halder et al.
BRAIN (2021)
New Insights in the Mechanisms of Impaired Redox Signaling and its Interplay With Inflammation and Immunity in Multiple Sclerosis
Danica Michalickova et al.
PHYSIOLOGICAL RESEARCH (2020)
Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development
Valentina Pegoretti et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Treatment of Multiple Sclerosis: A Review
Stephen L. Hauser et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition
Clare Walton et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients
Massimiliano Castellazzi et al.
JOURNAL OF NEUROINFLAMMATION (2019)
GDF-15, a mitochondrial disease biomarker, is associated with the severity of multiple sclerosis
Seitaro Nohara et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)
Mitochondrial Dysfunction and Multiple Sclerosis
Isabella Peixoto de Barcelos et al.
BIOLOGY-BASEL (2019)
Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis
Graham Campbell et al.
FEBS LETTERS (2018)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Lipoic acid in secondary progressive MS A randomized controlled pilot trial
Rebecca Spain et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)
The potential role for ocrelizumab in the treatment of multiple sclerosis: current evidence and future prospects
Per Soelberg Sorensen et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2016)
Multiple sclerosis: genetics, biomarkers, treatments
Pierre-Paul Axisa et al.
CURRENT OPINION IN NEUROLOGY (2016)
Multiple sclerosis: New insights and trends
Khaled Mohamed Mohamed Koriem
ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE (2016)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
MITOCHONDRIAL REACTIVE OXYGEN SPECIES (ROS) AND ROS-INDUCED ROS RELEASE
Dmitry B. Zorov et al.
PHYSIOLOGICAL REVIEWS (2014)
Decreased NAA in Gray Matter is Correlated with Decreased Availability of Acetate in White Matter in Postmortem Multiple Sclerosis Cortex
S. Li et al.
NEUROCHEMICAL RESEARCH (2013)
Mitochondria: In Sickness and in Health
Jodi Nunnari et al.
CELL (2012)
Pathophysiology of multiple sclerosis and the place of teriflunomide
R. Gold et al.
ACTA NEUROLOGICA SCANDINAVICA (2011)
Rotation and structure of FoF1-ATP synthase
Daichi Okuno et al.
JOURNAL OF BIOCHEMISTRY (2011)
Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter
Joshua M. Baughman et al.
NATURE (2011)
Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm
Helena Batoulis et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2010)
Is multiple sclerosis a mitochondrial disease?
Peizhong Mao et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes
Robert B. Hamanaka et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
The Role of Mitochondria in Apoptosis
Chunxin Wang et al.
ANNUAL REVIEW OF GENETICS (2009)
Mitochondrial changes within axons in multiple sclerosis
Don J. Mahad et al.
BRAIN (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Maturation of iron-sulfur proteins in eukaryotes: Mechanisms, connected processes, and diseases
Roland Lill et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression
J. van Horssen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression
William T. Regenold et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Mitochondrial DNA repair in aging and disease
Nadiya M. Druzhyna et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2008)
Elevated myeloperoxidase activity in white matter in multiple sclerosis
Elizabeth Gray et al.
NEUROSCIENCE LETTERS (2008)
Mitochondrial mechanism of neuroprotection by CART
Peizhong Mao et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE
Joel A. Black et al.
BRAIN (2006)
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
R Dutta et al.
ANNALS OF NEUROLOGY (2006)
Nitric oxide toxicity in CNS white matter: An in vitro study using rat optic nerve
G Garthwaite et al.
NEUROSCIENCE (2002)
The neuroimmunology of multiple sclerosis: Possible roles of T and B lymphocytes in immunopathogenesis
KC O'Connor et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2001)
Share Paper
